Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Heart Failure - A practical approach presented by the CardioNerds
Ultromics joins FNIH partnership to transform heart failure detection - Ultromics
Characterization of Screen Failures Among Patients Evaluated for Transcatheter Tricuspid Valve Repair (TriSelect-Study) | JACC: Cardiovascular Interventions
Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata - Stolfo - 2022 - European Journal of Heart Failure - Wiley Online Library
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions | Journal of the American Heart Association
Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function | American Journal of Physiology- Heart and Circulatory Physiology
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Cancers | Free Full-Text | Harnessing RKIP to Combat Heart Disease and Cancer
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Ponikowski - 2016 - European Journal of Heart Failure - Wiley Online Library
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction | Circulation: Arrhythmia and Electrophysiology
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Sensors | Free Full-Text | Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology - ScienceDirect
Precision medicine for heart failure based on molecular mechanisms: The 2019 ISHR Research Achievement Award Lecture - ScienceDirect
Novel Devices in Heart Failure: BAT, Atrial Shunts, and Phrenic Nerve Stimulation | JACC: Heart Failure
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? | The Egyptian Heart Journal | Full Text
Frontiers | Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data | Technology Networks
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Emerging Therapeutic Targets for Heart Failure | Current Cardiology Reports
